Sodium oxybate - CT Laboratories

Drug Profile

Sodium oxybate - CT Laboratories

Alternative Names: Alcover; SMO immediate release formulation - D&A Pharma

Latest Information Update: 26 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CT Laboratories
  • Developer CT Laboratories; G.L. Pharma
  • Class Hydroxybutyrates; Sleep disorder therapies; Small molecules
  • Mechanism of Action Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Alcoholism

Most Recent Events

  • 22 Dec 1999 Registered & Launched for Alcoholism in Austria (PO)
  • 01 Dec 1994 Launched for Alcoholism in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top